The Journal of Organic Chemistry
Note
1
MHz, CDCl3) δ 157.2, 141.1, 130.4, 123.9, 118.5, 114.5, 43.5. H
NMR data agree with those of Doyle et al.10
2-Bromo-N,N-dimethyl-4-nitroaniline (Table 3, Entry 18).
The title compound was prepared from 2-bromo-1-fluoro-4-nitro-
benzene (165.9 mg, 0.754 mmol) according to method B to yield 62.6
N,N-Dimethyl-2-nitro-4-(trifluoromethyl)aniline (Table 3,
Entries 9 and 10). The title compound was prepared from 1-
fluoro-2-nitro-4-(trifluoromethyl)benzene (627.7 mg, 3.002 mmol)
according to method A. The collected product was diluted with EtOAc
(100 mL) and washed with water (100 mL) and brine (100 mL), and
the organic phase was dried over MgSO4 and concentrated. The
residue was purified by column chromatography to yield 191.0 mg
1
mg (97%) without column chromatography: H NMR (600 MHz,
CDCl3) δ 8.39 (d, J = 2.7 Hz, 1H), 8.08 (dd, J = 9.0, 2.7 Hz, 1H), 6.97
(d, J = 9.0 Hz, 1H), 2.97 (s, 6H); 13C NMR (151 MHz, CDCl3) δ
1
157.2, 141.3, 130.4, 123.9, 118.4, 114.7, 43.5; H NMR data agrees
with those of Doyle et al.10
N,N-Dimethylbenzo[d]oxazol-2-amine (Table 3, Entry 19).
The title compound was prepared from 2-chlorobenzo[d]oxazole
(230.3 mg, 1.500 mmol) according to method B to yield 79.5 mg
(94%) without column chromatography. NMR data agree with those
of Cho et al.12
4-Chloro-N,N-dimethyl-2-nitroaniline (Table 3, Entry 20).
The title compound was prepared from 4-chloro-1-fluoro-2-nitro-
benzene (132.7 mg, 0.756 mmol) according to method B to yield 41.6
mg (79%). NMR data agree with those of Yang et al.14
N,N,4-Trimethyl-5-nitropyridin-2-amine (Table 3, Entry 21).
The title compound was prepared from 2-chloro-4-methyl-5-nitro-
pyridine (257.3 mg, 1.491 mmol) according to method B to yield 86.9
mg (92%): 1H NMR (600 MHz, CDCl3) δ 8.92 (s, 1H), 6.19 (s, 1H),
3.15 (s, 6H), 2.55 (s, 3H); 13C NMR (151 MHz, CDCl3) δ 160.2,
148.1, 144.8, 135.6, 106.5, 38.3, 22.2; HRMS calcd for C8H12N3O2 (M
+ H) 182.0924, found 182.0926.
1
(78%) of the title compound as a yellow oil: H NMR (600 MHz,
CDCl3) δ 8.04 (d, J = 1.5 Hz, 1H), 7.57 (dd, J = 9.0, 2.1 Hz, 1H), 7.08
(d, J = 9.0 Hz, 1H), 2.97 (s, 6H); 13C NMR (151 MHz, CDCl3) δ
147.8 (s), 136.8 (s), 129.6 (q, J = 3.3 Hz), 124.8 (q, J = 12.3 Hz),
123.7 (q, J = 270.8 Hz), 118.4 (q, J = 34.3 Hz), 117.8 (s), 42.1 (s);
HRMS calcd for C9H10F3N2O2 (M + H) 235.0689, found 235.0690.
Alternatively, the title compound was prepared from 1-fluoro-2-nitro-
4-(trifluoromethyl)benzene (315.1 mg, 1.507 mmol) according to
method B to yield 96.5 mg (82%).
N,N-Dimethyl-1H-benzo[d]imidazol-2-amine (Table 3, Entry
11). The title compound was prepared from 2-chloro-1H-benzo[d]-
imidazole (229.0 mg, 1.501 mmol) according to method A. The
collected product was diluted with water (100 mL), the product
extracted with EtOAc (100 mL), and the organic phase dried over
MgSO4 and concentrated. The residue was purified by column
5-Bromo-N,N-dimethyl-2-nitroaniline (Table 3, Entries 22
and 23). Attempted preparation from 4-bromo-2-fluoro-1-nitro-
benzene (335.2 mg, 1.524 mmol) according to method A was
unsuccessful, and no product or starting material was observed by
LC−MS. Instead, the title compound was prepared from 4-bromo-2-
fluoro-1-nitrobenzene (330.3 mg, 1.501 mmol) according to method B
but with the flow rate of each pump increased to 0.500 mL/min to
yield 125.8 mg (97%) without column chromatography: yellow
1
chromatography to yield 77.4 mg (92%) of the title compound: H
NMR (600 MHz, DMSO-d6) δ 7.16 (d, J = 7.7 Hz, 1H), 7.13 (d, J =
7.6 Hz, 1H), 6.91 (t, J = 7.4 Hz, 1H), 6.84 (t, J = 7.4 Hz, 1H), 3.03 (s,
6H); 13C NMR (151 MHz, DMSO-d6) δ 156.9, 143.8, 134.4, 120.2,
118.2, 114.8, 108.7, 38.1. 1H NMR data agree with those of El-Faham
et al.11
N,N-Dimethylbenzo[d]thiazol-2-amine (Table 3, Entries 12
and 13). The title compound was prepared from 2-chlorobenzo[d]-
thiazole (256.3 mg, 1.511 mmol) according to method A. The
collected product was diluted with water (100 mL), the product
extracted with EtOAc (100 mL), and the organic phase dried over
MgSO4 and concentrated. The residue was purified by column
chromatography to yield 80.9 mg (86%) of the title compound. NMR
data agree with those of Cho et al.12 Alternatively, the title compound
was prepared from 2-bromobenzo[d]thiazole (319.4 mg, 1.492 mmol)
according to method A to yield 71.8 mg (78%).
4-(Dimethylamino)-3-nitrobenzonitrile (Table 3, Entries 14
and 15). Attempted preparation of the title compound from 4-chloro-
3-nitrobenzonitrile (273.6 mg, 1.499 mmol) according to method A
afforded a complex mixture; LC−MS showed 14% product and 86%
unidentified side products. Alternatively, the title compound was
prepared from 4-chloro-3-nitrobenzonitrile (273.5 mg, 1.498 mmol)
according to method B to yield 96.3 mg (97%). NMR data agree with
those of Brzozowski et al.13
1
crystalline solid; mp 47−49 °C; H NMR (600 MHz, CDCl3) δ 7.62
(d, J = 8.7 Hz, 1H), 7.12 (d, J = 2.0 Hz, 1H), 6.88 (dd, J = 8.7, 2.0 Hz,
1H), 2.87 (s, 6H); 13C NMR (151 MHz, CDCl3) δ 146.9, 137.5,
128.2, 128.0, 120.8, 120.5, 42.4; HRMS calcd for C8H10BrN2O2 (M +
H) 244.9920, found 244.9912.
ASSOCIATED CONTENT
■
S
* Supporting Information
1H and 13C NMR spectra. This material is available free of
AUTHOR INFORMATION
Corresponding Author
■
Notes
2-(Dimethylamino)-4-methylquinoline-3-carbonitrile (Table
3, Entry 16). The title compound was prepared from 2-chloro-4-
methylquinoline-3-carbonitrile (304.1 mg, 1.501 mmol) according to
method B to yield 75.2 mg (68%).: pale yellow crystalline solid; mp
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
We thank the Danish Agency for Science, Technology and
Innovation for financial support.
■
1
101−102 °C; H NMR (600 MHz, CDCl3) δ 7.79 − 7.76 (m, 1H),
7.71 − 7.68 (m, 1H), 7.61 (ddd, J = 8.4, 6.8, 1.4 Hz, 1H), 7.29 (ddd, J
= 8.2, 6.8, 1.3 Hz, 1H), 3.25 (s, 6H), 2.81 (s, 3H); 13C NMR (151
MHz, CDCl3) δ 158.0, 154.6, 147.9, 132.3, 127.8, 124.3, 123.7, 121.9,
117.7, 97.9, 41.1, 17.7; HRMS calcd for C13H14N3 (M + H) 212.1182,
found 212.1176.
REFERENCES
■
(1) (a) Schlosser, M.; Bobbio, C.; Rausis, T. J. Org. Chem. 2005, 70,
2494. (b) Kourafalos, V. N.; Marakos, P.; Mikros, E.; Pouli, N.; Marek,
J.; Marek, R. Tetrahedron 2006, 62, 11987. (c) Kelley, J. L.; Linn, J. A.;
Rideout, J. L.; Soroko, F. E. J. Heterocycl. Chem. 1988, 25, 1255.
(d) Urner, R. S.; Bergstrom, F. W. J. Am. Chem. Soc. 1945, 67, 2108.
(2) (a) Coppinger, G. M. J. Am. Chem. Soc. 1954, 76, 1372.
(b) Heindel, N. D.; Kennewel, P. D. J. Chem. Soc., Chem. Commun.
1969, 38. (c) Wan, Y.; Alterman, M.; Larhed, M.; Hallberg, A. J. Org.
Chem. 2002, 67, 6232. (d) Kodimuthali, A.; Mungara, A.; Prasunamba,
P. L.; Pal, M. J. Brazil. Chem. Soc. 2010, 21, 1439.
Ethyl 4-(Dimethylamino)quinoline-3-carboxylate (Table 3,
Entry 17). The title compound was prepared from ethyl 4-
chloroquinoline-3-carboxylate (353.7 mg, 1.501 mmol) according to
method B but with the temperature of the second reactor increased to
1
50 °C: yield 101.0 mg (79%); yellow gum; H NMR (600 MHz,
CDCl3) δ 8.84 (s, 1H), 8.07 (dd, J = 8.5, 1.0 Hz, 1H), 7.97 (dd, J =
8.4, 0.8 Hz, 1H), 7.60 (ddd, J = 8.3, 6.8, 1.4 Hz, 1H), 7.41 (ddd, J =
8.3, 6.8, 1.3 Hz, 1H), 4.37 (q, J = 7.1 Hz, 2H), 3.03 (s, 6H), 1.36 (t, J =
7.2 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 167.4, 157.4, 151.2,
150.5, 130.2, 129.9, 125.7, 125.4, 124.9, 116.8, 61.4, 44.2, 14.4; HRMS
calcd for C14H17N2O2 (M + H) 245.1285, found 245.1275.
(3) (a) Agarwal, A.; Chauhan, P. M. S. Synth. Commun. 2004, 34,
2925. (b) Cechova, L.; Jansa, P.; Sala, M.; Dracinsky, M.; Holy, A.;
Janeba, Z. Tetrahedron 2011, 67, 866.
4194
dx.doi.org/10.1021/jo400390t | J. Org. Chem. 2013, 78, 4190−4195